AGL - agilon health, inc. Stock Price, Fair Value and News

4.45USD-0.50 (-10.10%)Market Closed

Market Summary

USD4.45-0.50

Market Closed

-10.10%

AGL Stock Price

View Fullscreen

AGL RSI Chart

AGL Valuation

Market Cap

1.8B

Price/Earnings (Trailing)

-6.94

Price/Sales (Trailing)

0.42

EV/EBITDA

-10.17

Price/Free Cashflow

-10.59

AGL Price/Sales (Trailing)

AGL Profitability

EBT Margin

-4.51%

Return on Equity

-39.68%

Return on Assets

-15.08%

Free Cashflow Yield

-9.44%

AGL Fundamentals

AGL Revenue

Revenue (TTM)

4.3B

Rev. Growth (Yr)

120.54%

Rev. Growth (Qtr)

-32.92%

AGL Earnings

Earnings (TTM)

-262.6M

Earnings Growth (Yr)

-308.09%

Earnings Growth (Qtr)

-633.02%

Breaking Down AGL Revenue

Last 7 days

-14.1%

Last 30 days

-16.3%

Last 90 days

-40.6%

Trailing 12 Months

-84.4%

How does AGL drawdown profile look like?

AGL Financial Health

Current Ratio

1.51

Debt/Equity

0.05

Debt/Cashflow

-4.83

AGL Investor Care

Buy Backs (1Y)

1.41%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	2.9B	3.3B	3.9B	4.3B
2022	1.8B	1.9B	2.2B	2.4B
2021	1.3B	1.5B	1.7B	1.5B
2020	900.4M	1.0B	1.1B	1.2B
2019	0	0	0	794.4M
2018	0	0	0	474.8M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of agilon health, inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 14, 2024	desai veeral	bought	-	-	11,956	chief strategy & dev. officer
Mar 14, 2024	shaker benjamin	sold (taxes)	-498,241	5.23	-95,266	chief markets officer
Mar 14, 2024	kornitzer benjamin	sold (taxes)	-9,848	5.23	-1,883	chief med. & quality officer
Mar 14, 2024	shaker benjamin	bought	-	-	274,455	chief markets officer
Mar 14, 2024	desai veeral	sold (taxes)	-25,627	5.23	-4,900	chief strategy & dev. officer
Mar 14, 2024	venkatachaliah girish	sold (taxes)	-9,848	5.23	-1,883	chief technology officer
Mar 14, 2024	bensley timothy	sold (taxes)	-35,307	5.23	-6,751	chief financial officer
Mar 14, 2024	kornitzer benjamin	bought	-	-	5,434	chief med. & quality officer
Mar 14, 2024	venkatachaliah girish	bought	-	-	5,434	chief technology officer
Mar 14, 2024	bensley timothy	bought	-	-	14,945	chief financial officer

Which funds bought or sold AGL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 12, 2024	AdvisorNet Financial, Inc	reduced	-15.93	-82,546	57,035	-%
Apr 12, 2024	NORTHWEST INVESTMENT COUNSELORS, LLC	new	-	415	415	-%
Apr 10, 2024	Yarbrough Capital, LLC	unchanged	-	-227,898	215,531	0.01%
Apr 09, 2024	Renaissance Capital LLC	added	2.99	-1,163,070	1,165,840	0.60%
Apr 05, 2024	CWM, LLC	added	252	5,000	11,000	-%
Apr 05, 2024	GAMMA Investing LLC	added	911	8,591	9,498	-%
Mar 27, 2024	NOMURA HOLDINGS INC	new	-	308,730	308,730	-%
Mar 22, 2024	PNC FINANCIAL SERVICES GROUP, INC.	reduced	-65.08	-12,641	4,142	-%
Mar 11, 2024	VANGUARD GROUP INC	added	0.78	-144,958,000	358,632,000	0.01%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	284	6,980,540	11,049,500	-%

Are Funds Buying or Selling AGL?

Are funds buying AGL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AGL

No. of Funds

Unveiling agilon health, inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	7.04%	28,576,261	SC 13G
Feb 12, 2024	morgan stanley	10.8%	43,816,286	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 09, 2024	capital world investors	13.6%	55,218,496	SC 13G/A
Feb 08, 2024	cd&r vector holdings, l.p.	24.6%	1e+08	SC 13G/A
Feb 08, 2024	wellington management group llp	10.47%	42,510,030	SC 13G/A
Sep 08, 2023	morgan stanley	10.7%	43,556,373	SC 13G/A
Sep 08, 2023	wellington management group llp	10.14%	41,124,989	SC 13G/A
Mar 10, 2023	capital world investors	10.3%	42,425,420	SC 13G/A
Feb 13, 2023	capital world investors	9.2%	37,918,473	SC 13G/A

Recent SEC filings of agilon health, inc.

View All Filings

Date Filed	Form Type	Document
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Mar 18, 2024	4	Insider Trading
Feb 27, 2024	8-K	Current Report
Feb 27, 2024	10-K	Annual Report
Feb 13, 2024	SC 13G	Major Ownership Report
Feb 12, 2024	SC 13G/A	Major Ownership Report
Feb 09, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to agilon health, inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	410.7B	371.6B	-9.23%	-12.95%	18.35	1.11	14.64%	11.24%
CI	102.0B	195.3B	-0.90%	34.65%	18.99	0.52	8.17%	-20.79%
CVS	86.8B	357.8B	-10.90%	-7.68%	10.39	0.24	10.95%	93.52%
HCA	85.3B	65.0B	0.18%	18.00%	16.28	1.31	7.86%	-7.11%
CNC	38.9B	154.0B	-3.67%	6.80%	14.39	0.25	6.54%	124.79%
UHS	11.5B	14.3B	-4.30%	22.39%	16.07	0.81	6.59%	6.24%
DVA	11.4B	12.1B	-4.93%	54.73%	16.48	0.94	4.57%	23.40%
MID-CAP
CHE	9.3B	2.3B	-4.81%	9.59%	34.17	4.11	6.06%	9.17%
ACHC	6.7B	2.9B	-6.00%	-3.46%	-311.45	2.3	12.20%	-107.93%
AMEH	2.2B	1.4B	-1.50%	0.56%	35.86	1.57	21.19%	34.42%
AMN	2.2B	3.8B	-2.74%	-34.13%	10.27	0.57	-27.73%	-52.50%
SMALL-CAP
ADUS	1.6B	1.1B	0.06%	-12.91%	25.13	1.48	11.31%	35.83%
BKD	1.2B	3.0B	5.33%	55.67%	-6.33	0.4	6.74%	20.73%
BEAT	48.4M	-	-23.65%	-14.81%	-3.31	-	-	-12.94%
AMS	18.2M	21.3M	11.67%	2.14%	34.08	0.85	8.00%	-62.25%

agilon health, inc. News

Latest updates

agilon health, inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Revenue	-32.9%	815,504,000	1,215,660,000	1,149,052,000	1,136,147,000	369,783,000	694,858,000	670,134,000	653,445,000	150,821,000	458,613,000	498,956,000	413,104,000	321,007,000	312,684,000	293,594,000	291,048,000	-	-
Costs and Expenses	-22.9%	975,106,000	1,264,631,000	1,178,873,000	-	423,848,000	724,376,000	691,186,000	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	1,129,886,000	758,892,000	724,376,000	691,186,000	654,188,000	510,759,000	494,214,000	797,319,000	425,219,000	360,750,000	322,528,000	294,846,000	296,882,000	-	-
S&GA Expenses	-14.6%	63,277,000	74,138,000	81,499,000	66,846,000	64,051,000	51,980,000	51,924,000	39,834,000	25,521,000	46,643,000	317,561,000	37,777,000	45,581,500	30,368,000	34,248,000	27,605,000	-	-
EBITDA Margin	-195.2%	-0.04	-0.01	-0.02	-0.02	-0.03	-0.04	-0.04	-0.18	-0.21	-0.22	-0.22	-0.03	-	-	-	-	-	-
Interest Expenses	14.2%	1,886,000	1,651,000	1,588,000	1,533,000	1,668,000	1,000,000	945,000	871,000	840,000	867,000	1,498,000	2,941,000	1,953,000	1,953,000	2,080,000	2,149,000	-	-
Income Taxes	-77.9%	267,000	1,210,000	1,073,000	-1,759,000	572,000	559,000	580,000	-71,000	179,000	256,000	435,000	16,000	791,000	35,000	39,000	-	-	-
Earnings Before Taxes	-437.3%	-162,667,000	-30,273,000	-15,722,000	14,200,000	-40,923,000	-29,944,000	-20,458,000	655,000	-35,625,000	-36,737,000	-296,894,000	-13,720,000	-38,810,000	-12,266,000	-3,406,000	-7,861,000	-	-
EBT Margin	-139.8%	-0.05	-0.02	-0.02	-0.03	-0.04	-0.04	-0.05	-0.19	-0.22	-0.23	-0.23	-0.05	-	-	-	-	-	-
Net Income	-633.0%	-230,433,000	-31,436,000	-16,749,000	16,022,000	-56,466,000	-30,668,000	-20,649,000	1,230,000	-56,721,000	-35,843,000	-298,845,000	-15,078,000	-24,215,000	-11,827,000	-7,911,000	-16,099,000	-	-
Net Income Margin	-165.7%	-0.06	-0.02	-0.02	-0.03	-0.04	-0.04	-0.05	-0.19	-0.22	-0.22	-0.23	-0.04	-	-	-	-	-	-
Free Cashflow	-280.6%	-65,098,000	-17,105,000	-25,298,000	-64,528,000	-53,448,000	-786,000	-64,718,000	-27,282,000	-52,297,000	-21,661,000	-39,759,000	-41,006,000	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2019Q4
Assets	-23.6%	1,741	2,278	2,353	2,170	1,697	1,870	1,841	1,855	1,586	1,685	1,702	574	446	403
Current Assets	-24.4%	1,480	1,957	2,045	1,876	1,451	1,634	1,601	1,628	1,367	1,453	1,480	418	294	246
Cash Equivalents	-36.1%	108	168	191	394	465	564	684	1,022	1,049	1,082	1,109	105	128	139
Net PPE	5.2%	28.00	26.00	24.00	22.00	20.00	18.00	16.00	13.00	9.00	6.00	5.00	5.00	6.00	7.00
Goodwill	-61.3%	24.00	62.00	62.00	62.00	3.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00
Liabilities	-23.2%	1,080	1,406	1,473	1,088	657	785	737	744	495	558	551	563	422	354
Current Liabilities	-24.9%	977	1,301	1,362	973	535	658	605	610	357	423	412	372	267	200
Long Term Debt	-7.1%	32.00	35.00	36.00	37.00	38.00	40.00	41.00	42.00	43.00	45.00	46.00	99.00	65.00	67.00
LT Debt, Current	25.0%	6.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	4.00	-	3.00	3.00
LT Debt, Non Current	-7.1%	32.00	35.00	36.00	37.00	38.00	40.00	41.00	42.00	43.00	45.00	46.00	99.00	65.00	67.00
Shareholder's Equity	-24.1%	662	872	879	1,082	1,041	1,085	1,103	1,111	1,092	1,127	1,150	-	-284	-
Retained Earnings	-21.0%	-1,326	-1,096	-1,064	-1,048	-1,064	-1,007	-977	-956	-957	-900	-865	-566	-551	-491
Additional Paid-In Capital	0.8%	1,987	1,971	1,947	2,130	2,107	2,095	2,076	2,064	2,046	2,025	2,012	266	264	257
Shares Outstanding	0.1%	406	406	405	414	412	411	407	402	373	365	352	326	-	-
Minority Interest	-6.6%	-0.82	-0.77	-0.72	-0.67	-0.61	-0.53	-0.46	-0.37	-0.30	-0.28	-0.17	-0.07	-	-
Float	-	-	-	5,200	-	-	-	4,500	-	-	-	6,600	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Cashflow From Operations	-369.9%	-61,166	-13,018	-21,204	-60,811	-49,959	2,647	-60,263	-23,233	-48,897	-19,143	-39,291	-40,828	-13,339	-4,367	-9,371	-26,127	-	-
Share Based Compensation	-25.2%	15,515	20,736	19,572	13,672	9,951	7,907	6,553	3,970	4,414	11,960	274,548	1,472	1,837	1,558	2,155	1,071	-	-
Cashflow From Investing	80.0%	-2,203	-11,034	20,032	-50,814	-7,970	-130,938	-296,611	-8,869	-2,603	-11,565	-67,264	-9,074	23,274	1,143	-2,670	319	-	-
Cashflow From Financing	-159.9%	-845	1,410	-202,037	8,339	1,130	9,111	4,309	13,506	10,417	896	1,112,779	30,298	-760	-6,141	4,154	27,368	-	-
Buy Backs	-	1,409	-	201,564	-	-	-	-	-	-	-	-	-	-	6,742	-	-	-	-

AGL Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Total revenues	$ 4,316,363	$ 2,388,220	$ 1,521,494
Expenses:
General and administrative (including noncash stock-based compensation expense of $69,326, $28,069, and $291,672, respectively)	285,760	207,789	427,502
Depreciation and amortization	16,043	8,949	10,484
Total expenses	4,548,496	2,493,598	1,893,736
Income (loss) from operations	(232,133)	(105,378)	(372,242)
Other income (expense):
Income (loss) from equity method investments	16,489	10,720	(6,766)
Other income (expense), net	27,840	13,930	2,178
Gain (loss) on lease terminations	0	(5,458)	0
Interest expense	(6,658)	(4,484)	(6,146)
Income (loss) before income taxes	(194,462)	(90,670)	(382,976)
Income tax benefit (expense)	(791)	(1,640)	(886)
Income (loss) from continuing operations	(195,253)	(92,310)	(383,862)
Discontinued operations:
Income (loss) before gain (loss) on sales and income taxes	(20,002)	(14,528)	(25,085)
Gain (loss) on sales of assets, net	(47,548)	0	473
Income tax benefit (expense)	0	(26)	1,687
Total discontinued operations	(67,550)	(14,554)	(22,925)
Net income (loss)	(262,803)	(106,864)	(406,787)
Noncontrolling interests’ share in (earnings) loss	207	311	300
Net income (loss) attributable to common shares	$ (262,596)	$ (106,553)	$ (406,487)
Net income (loss) per common share, basic and diluted
Continuing operations basic (in dollars per share)	$ (0.48)	$ (0.22)	$ (1.03)
Continuing operations diluted (in dollars per share)	(0.48)	(0.22)	(1.03)
Discontinued operations basic (in dollars per share)	(0.16)	(0.04)	(0.06)
Discontinued operations diluted (in dollars per share)	$ (0.16)	$ (0.04)	$ (0.06)
Weighted average shares outstanding, basic (in shares)	408,917	408,154	372,931
Weighted average shares outstanding, diluted (in shares)	408,917	408,154	372,931
Medical Services
Revenues:
Total revenues	$ 4,307,350	$ 2,384,889	$ 1,518,322
Expenses:
Expenses	4,008,659	2,093,860	1,357,326
Other Operating
Revenues:
Total revenues	9,013	3,331	3,172
Expenses:
Expenses	$ 238,034	$ 183,000	$ 98,424

AGL Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 107,570	$ 465,302
Restricted cash and equivalents	6,759	10,610
Marketable securities	380,773	411,901
Receivables, net	942,461	492,364
Prepaid expenses and other current assets, net	42,513	31,572
Current assets of discontinued operations	0	39,525
Total current assets	1,480,076	1,451,274
Property and equipment, net	27,576	19,937
Intangible assets, net	63,769	18,448
Goodwill	24,133	2,513
Other assets	145,312	105,861
Non-current assets of discontinued operations	0	99,435
Total assets	1,740,866	1,697,468
Current liabilities:
Medical claims and related payables	737,724	300,798
Accounts payable and accrued expenses	233,182	177,428
Current portion of long-term debt	6,250	5,000
Current liabilities of discontinued operations	0	51,865
Total current liabilities	977,156	535,091
Long-term debt, net of current portion	32,308	38,482
Other liabilities	70,381	82,492
Non-current liabilities of discontinued operations	0	794
Total liabilities	1,079,845	656,859
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 406,387 and 412,385 shares issued and outstanding, respectively	4,064	4,124
Additional paid-in capital	1,986,899	2,106,886
Accumulated deficit	(1,326,826)	(1,064,230)
Accumulated other comprehensive income (loss)	(2,298)	(5,560)
Total agilon health, inc. stockholders' equity (deficit)	661,839	1,041,220
Noncontrolling interests	(818)	(611)
Total stockholders’ equity (deficit)	661,021	1,040,609
Total liabilities and stockholders’ equity (deficit)	$ 1,740,866	$ 1,697,468

About agilon health, inc.

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

CEO	Mr. Steven Jackson Sell
WEBSITE	agilonhealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	747

agilon health, inc. Frequently Asked Questions

What is the ticker symbol for agilon health, inc.? What does AGL stand for in stocks?

AGL is the stock ticker symbol of agilon health, inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of agilon health, inc. (AGL)?

As of Mon Apr 15 2024, market cap of agilon health, inc. is 1.82 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AGL stock?

You can check AGL's fair value in chart for subscribers.

What is the fair value of AGL stock?

You can check AGL's fair value in chart for subscribers. The fair value of agilon health, inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of agilon health, inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AGL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is agilon health, inc. a good stock to buy?

The fair value guage provides a quick view whether AGL is over valued or under valued. Whether agilon health, inc. is cheap or expensive depends on the assumptions which impact agilon health, inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AGL.

What is agilon health, inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, AGL's PE ratio (Price to Earnings) is -6.94 and Price to Sales (PS) ratio is 0.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AGL PE ratio will change depending on the future growth rate expectations of investors.